OverviewBreast cancer is the most commonly diagnosed cancer in women in the United States, with an estimated 234,190 cases of invasive breast cancer diagnosed and an estimated 40,290 cancer deaths from breast cancer in 2015.1 This highlights the need for effective breast cancer screening and risk reduction strategies.For women without a personal history of breast cancer, risk factors for its development can be
AbstractBreast cancer is the most frequently diagnosed malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. To assist women who are at increased risk of developing breast cancer and their physicians in the application of individualized strategies to reduce breast cancer risk, NCCN has developed these guidelines for breast cancer risk reduction. (J Natl Compr Canc Netw 2015;13:880-915)
NCCN Categories of Evidence and ConsensusCategory 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate. Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate. © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN.
Disclosures for the NCCN Breast Cancer Risk Reduction PanelAt the beginning of each NCCN Guidelines panel meeting, panel members review all potential conflicts of interest. NCCN, in keeping with its commitment to public transparency, publishes these disclosures for panel members, staff, and NCCN itself. grouped into categories, including familial/genetic factors; factors related to age, demographics, reproductive history, and lifestyle; and other factors, such as number of breast biopsies, especially those with a finding of flat epithelial atypia, atypical hyperplasia (AH), or lobular carcinoma in situ (LCIS); breast density: or prior thoracic irradiation that occurred before 30 years of age (eg, for the treatment of Hodgkin lymphoma).Estimating breast cancer risk for an individual patient is difficult, and most breast cancers are not attributable to risk factors other than female gender and increasing age. 2 The development of effective strategies for the reduction of breast cancer incidence has also been difficult, because few of the existing risk factors are modifiable and some of the potentially modifiable risk factors have social implications extending beyond concerns for breast cancer (eg, age at first live birth). Nevertheless, effective breast cancer risk reduction strategies, such as use of risk reduction agents and risk reduction surgery, have been identified. Women and their physicians considering interventions to reduce breast cancer risk must balance the demonstrated benef...